Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study
Yang K, Yang X, Jin C, et al.
BMJ. Pub. online 12 Jun 2024.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
The effect of eicosapentaenoic and docosahexaenoic acid supplementation on coronary artery calcium progression in subjects with diabetes and coronary artery disease: a secondary analysis of a randomized trial
Asbeutah AA, Daher R, Malik A, et al.
Am J Cardiol. Pub. online 15 Jun 2024.
Leggi
The quality of care in type 1 and type 2 diabetes – A 2023 update of the AMD Annals Initiative
Russo G, De Cosmo S, Di Bartolo P, et al.
Diabetes Res Clin Pract. Pub. online 13 Jun 2024.
Leggi
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study
Napoli R, Nicolucci A, Larosa M, et al.
Diabetes Obes Metab. Pub. online 10 Jun 2024.
Leggi
Data-driven phenotyping of presymptomatic type 1 diabetes using longitudinal autoantibody profiles
Ghalwash M, Anand V, Ng K, et al.
Diabetes Care. Pub. online 11 Jun 2024.
Leggi
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial
Kim NH, Moon JS, Lee YH, et al.
Diabetes Obes Metab. Pub. online 11 Jun 2024.
Leggi
Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective
Del Prato S, Giorgino F, Szafranski K, Poon Y
Diabetes Obes Metab. Pub. online 10 Jun 2024.
Leggi
How do lifestyle factors modify the association between genetic predisposition and obesity-related phenotypes? A 4-way decomposition analysis using UK Biobank
Zhang M, Ward J, Strawbridge RJ, et al.
BMC Med. Pub. online 10 Jun 2024.
Leggi
Key results from observational studies and real-world evidence of sodium-glucose cotransporter-2 inhibitor effectiveness and safety in reducing cardio-renal risk
Nyström T
Diabetes Obes Metab. Pub. online 10 Jun 2024.
Leggi
A phase 2 randomized trial of survodutide in MASH and fibrosis
Sanyal AJ, Bedossa P, Fraessdorf M, et al.
N Engl J Med. Pub. online 7 Jun 2024.
Leggi